Experimental Drug Reverses Paralysis and Vision Loss in MS Mouse Model

A new drug developed by a UVA Health scientist has demonstrated the ability to reverse paralysis and vision loss in a mouse model of multiple sclerosis. This finding is significant as current MS treatments focus on preventing future inflammation rather than restoring lost neurological function.

Originally published by gnews